2-Methyl-2-[4-[3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl]phenoxy]propanoic acid (BioDeep_00000180591)

   

human metabolite blood metabolite


代谢物信息卡片


2-methyl-2-[4-(3-{1-[(4-methylphenyl)methyl]-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl}propyl)phenoxy]propanoic acid

化学式: C23H27N3O4 (409.2001)
中文名称: 2-[4-[3-[2,5-二氢-1-[(4-甲基苯基)甲基]-5-氧代-1H-1,2,4-T噻唑-3-基]丙基]苯氧基]-2-甲基-丙酸
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC1=CC=C(C=C1)CN2C(=O)NC(=N2)CCCC3=CC=C(C=C3)OC(C)(C)C(=O)O
InChI: InChI=1S/C23H27N3O4/c1-16-7-9-18(10-8-16)15-26-22(29)24-20(25-26)6-4-5-17-11-13-19(14-12-17)30-23(2,3)21(27)28/h7-14H,4-6,15H2,1-3H3,(H,27,28)(H,24,25,29)

描述信息

同义名列表

5 个代谢物同义名

2-methyl-2-[4-(3-{1-[(4-methylphenyl)methyl]-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl}propyl)phenoxy]propanoic acid; 2-Methyl-2-[4-(3-{1-[(4-methylphenyl)methyl]-5-oxo-2,5-dihydro-1H-1,2,4-triazol-3-yl}propyl)phenoxy]propanoate; 2-Methyl-2-[4-[3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl]phenoxy]propanoic acid; 2-methyl-2-[4-(3-{1-[(4-methylphenyl)methyl]-5-oxo-4H-1,2,4-triazol-3-yl}propyl)phenoxy]propanoic acid; LY518674



数据库引用编号

7 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表


文献列表

  • Amit V Khera, John S Millar, Giacomo Ruotolo, Ming-Dauh Wang, Daniel J Rader. Potent peroxisome proliferator-activated receptor-α agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndrome. European heart journal. 2015 Nov; 36(43):3020-2. doi: 10.1093/eurheartj/ehv291. [PMID: 26112886]
  • Ashish Shah, Daniel J Rader, John S Millar. The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans. Atherosclerosis. 2010 May; 210(1):35-40. doi: 10.1016/j.atherosclerosis.2009.11.010. [PMID: 20005515]
  • Masaki Ogata, Maki Tsujita, Mohammad Anwar Hossain, Nobukatsu Akita, Frank J Gonzalez, Bart Staels, Shogo Suzuki, Tatsuya Fukutomi, Genjiro Kimura, Shinji Yokoyama. On the mechanism for PPAR agonists to enhance ABCA1 gene expression. Atherosclerosis. 2009 Aug; 205(2):413-9. doi: 10.1016/j.atherosclerosis.2009.01.008. [PMID: 19201410]
  • John S Millar, Danielle Duffy, Ramprasad Gadi, LeAnne T Bloedon, Richard L Dunbar, Megan L Wolfe, Rajesh Movva, Ashish Shah, Ilia V Fuki, Mary McCoy, Cynthia J Harris, Ming-Dauh Wang, Daniel C Howey, Daniel J Rader. Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome. Arteriosclerosis, thrombosis, and vascular biology. 2009 Jan; 29(1):140-6. doi: 10.1161/atvbaha.108.171223. [PMID: 18988892]
  • Steven E Nissen, Stephen J Nicholls, Kathy Wolski, Daniel C Howey, Ellen McErlean, Ming-Dauh Wang, Elisa V Gomez, John M Russo. Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials. JAMA. 2007 Mar; 297(12):1362-73. doi: 10.1001/jama.297.12.1362. [PMID: 17384435]
  • Jai Pal Singh, Raymond Kauffman, William Bensch, Guoming Wang, Pam McClelland, James Bean, Chahrzad Montrose, Nathan Mantlo, Asavari Wagle. Identification of a novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic acid (LY518674), that produces marked changes in serum lipids and apolipoprotein A-1 expression. Molecular pharmacology. 2005 Sep; 68(3):763-8. doi: 10.1124/mol.105.010991. [PMID: 15933217]